Transdermal Allergy Immunotherapy Study Shows Promise As An Alternative to Injections

Final results from the RELIEF Study Released

Topical Analgesics Reduce Opioid Usage over 3 and 6-months

“Traditional Allergy Immunotherapy consists of multiple years of Injections (sub-cutaneous immunotherapy- (SCIT)). We now have preliminary evidence that supplying allergens through topical administration shows a decrease in IgE levels and may prove to be a viable alternative to allergy shots and the millions of people who are allergy sufferers. We are conducting more clinical trials and excited to expand on these initial results.”

Peter Hurwitz
President, Clarity Science LLC

“The data from our recent studies showed that there are alternative pain management treatment options available for healthcare professionals to help address a patient’s pain. These options may lead to a reduced focus on Opioid prescribing and other oral analgesics and their side effects and have a significant and positive impact on patient care and outcomes.”

Peter Hurwitz
President, Clarity Science LLC

Conference & Publications Highlights

PAINWeek National Conference

September 8-12, 2020
Las Vegas, Nevada, USA

WIP World Institute of Pain

May 20-23, 2020
Rome, Italy

IASP International Association for the Study of Pain

August 4-8, 2020
Amsterdam, Netherlands

News & Announcements

Proud member of the
            Society of Clinical Research Associates (SOCRA).